Octreotide Adverse Reaction
1 clinical trials · Condition
◉ Watch Octreotide Adverse Reaction
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety Evaluation of Octreotide in the Treatment of Congenital Hyperinsulinemia (NCT05171751) | Beijing Children's Hospital | 2021-11-01 |
Track Octreotide Adverse Reaction automatically
Every clearance here is in the API, with alerts when new ones post.